David S. Zaccardelli
Net Worth

Last updated:

What is David S. Zaccardelli net worth?

The estimated net worth of Dr. David S. Zaccardelli is at least $1,516,975,141 as of 6 Dec 2024. He owns shares worth $1,496,044,481 as insider, has earned $18,124,140 from insider trading and has received compensation worth at least $2,806,520 in Verona Pharma plc.

What is the salary of David S. Zaccardelli?

Dr. David S. Zaccardelli salary is $701,630 per year as Pres, Chief Executive Officer & Executive Director in Verona Pharma plc.

How old is David S. Zaccardelli?

Dr. David S. Zaccardelli is 60 years old, born in 1965.

What stocks does David S. Zaccardelli currently own?

As insider, Dr. David S. Zaccardelli owns shares in one company:

Company Title Shares Price per share Total value
Verona Pharma plc (VRNA) Pres, Chief Executive Officer & Executive Director 14,204,752 $105.32 $1,496,044,481

What does Verona Pharma plc do?

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

VRNA logo
VRNA
Verona Pharma plc
$105.32

David S. Zaccardelli insider trading

Verona Pharma plc

Dr. David S. Zaccardelli has made 39 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently he sold 162,800 units of VRNA stock worth $815,465 on 6 Dec 2024.

The largest trade he's ever made was exercising 640,264 units of VRNA stock on 5 Dec 2024. As of 6 Dec 2024 he still owns at least 14,204,752 units of VRNA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Ordinary Shares 162,800 $5.01 $815,465
Sale
Ordinary Shares 640,264 $5.01 $3,205,162
Sale
Ordinary Shares 67,608 $5 $338,175
Sale
Ordinary Shares 3,200 $5 $16,000
Sale
Ordinary Shares 98,888 $5.01 $495,033
Sale
Ordinary Shares 23,240 $5 $116,200
Sale
Ordinary Shares 1,600 $5 $8,000
Sale
Ordinary Shares 2,400 $5 $12,000
Sale
Ordinary Shares 94,144 $4.39 $413,480
Sale
Ordinary Shares 46,888 $4.38 $205,182
Sale
Ordinary Shares 4,800 $4.38 $21,005
Sale
Ordinary Shares 140,000 $4.38 $612,780
Sale
Ordinary Shares 16 $4.38 $70
Sale
Ordinary Shares 157,912 $4.39 $692,760
Sale
Ordinary Shares 110,456 $4.38 $483,797
Sale
Ordinary Shares 245,784 $4.38 $1,076,780
Sale
Ordinary Shares 600,000 $3.76 $2,254,200
Sale
Ordinary Shares 390,184 $3.2 $1,248,979
Sale
Ordinary Shares 8,216 $3.25 $26,702
Sale
Ordinary Shares 1,600 $3.13 $5,008
Sale
Ordinary Shares 8,616 $2.47 $21,264
Sale
Ordinary Shares 150,000 $2.5 $374,850
Sale
Ordinary Shares 117,272 $2.54 $297,754
Sale
Ordinary Shares 73,704 $2.59 $191,114
Sale
Ordinary Shares 105,944 $2.68 $283,824
Sale
Ordinary Shares 455,536 $2.58 $1,173,461
Sale
Ordinary Shares 432,928 $2.56 $1,106,997
Sale
Ordinary Shares 600,000 $2.12 $1,269,600
Sale
Ordinary Shares 32,904 $1.67 $55,048
Sale
Ordinary Shares 600,000 $1.75 $1,050,000
Sale
Ordinary Shares 32,904 $0.7 $23,033
Sale
Ordinary Shares 32,904 $0.5 $16,320
Sale
Ordinary Shares 52,056 $0.73 $37,793
Sale
Ordinary Shares 52,056 $0.64 $33,368
Sale
Ordinary Shares 18,400 $0.74 $13,671
Sale
Ordinary Shares 16,000 $0.76 $12,208
Sale
Ordinary Shares 33,656 $0.76 $25,511
Sale
Ordinary Shares 52,056 $0.81 $41,905
Sale
Ordinary Shares 43,392 $1.14 $49,640

Verona Pharma key executives

Verona Pharma plc executives and other stock owners filed with the SEC: